Showing results (1-10 of 4) with videos related to
Sort By:
Pageof 1
Health Technology Assessment (Winchester, England)|January 29, 2015
Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for advanced recurrent or refractory ovarian cancer: a systematic review and economic evaluationSteven J Edwards, Samantha Barton, Elizabeth Thurgar, et al.Health Technology Assessment (Winchester, England)|April 2, 2016
Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluationElizabeth Thurgar, Samantha Barton, Charlotta Karner, et al.Frontline Gastroenterology|March 29, 2018
Challenging current views on bile acid diarrhoea and malabsorptionMatthew Kurien, Elizabeth Thurgar, Ashley Davies, et al.Journal of Medical Economics|April 19, 2021
Cost-effectiveness of pembrolizumab compared with chemotherapy in the US for women with previously treated deficient mismatch repair or high microsatellite instability unresectable or metastatic endometrial cancerElizabeth Thurgar, Mark Gouldson, Suzette Matthijsse, et al.Pageof 1